← FDA Drug Approvals (Drugs@FDA)

VESICARE LS

NDA · New Drug Application · Sponsor: ASTELLAS · Approved 2020-05-26

Drug application

FDA Application #

NDA209529

Application type

New Drug Application

Brand name

VESICARE LS

Generic name

SOLIFENACIN SUCCINATE

Active ingredients

SOLIFENACIN SUCCINATE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

ASTELLAS

Manufacturer

Astellas Pharma US, Inc.

First approval

2020-05-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown